Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of Cannabis sativa Using GC-FID

Abstract

Cannabis (Cannabis sativa L.) is an annual herbaceous plant that belongs to the family Cannabaceae. Trans-Δ⁹-tetrahydrocannabinol (Δ⁹-THC) and cannabidiol (CBD) are the two major phytocannabinoids accounting for over 40% of the cannabis plant extracts, depending on the variety. At the University of Mississippi, different strains of C. sativa, with different concentration ratios of CBD and Δ⁹-THC, have been tissue cultured via micropropagation and cultivated. A GC-FID method has been developed and validated for the qualitative and quantitative analysis of acid and neutral cannabinoids in C. sativa extracts. The method involves trimethyl silyl derivatization of the extracts. These cannabinoids include tetrahydrocannabivarian, CBD, cannabichromene, trans-Δ⁸-tetrahydrocannabinol, Δ⁹-THC, cannabigerol, cannabinol, cannabidiolic acid, cannabigerolic acid, and Δ⁹-tetrahydrocannabinolic acid-A. The concentration-response relationship of the method indicated a linear relationship between the concentration and peak area ratio with R² > 0.999 for all 10 cannabinoids. The precision and accuracy of the method were found to be ≤ 15% and ± 5%, respectively. The limit of detection range was 0.11 – 0.19 µg/mL, and the limit of quantitation was 0.34 – 0.56 µg/mL for all 10 cannabinoids. The developed method is simple, sensitive, reproducible, and suitable for the detection and quantitation of acidic and neutral cannabinoids in different extracts of cannabis varieties. The method was applied to the analysis of these cannabinoids in different parts of the micropropagated cannabis plants (buds, leaves, roots, and stems).

Key words

Cannabis sativa L. - Cannabaceae - cannabinoids - GC-FID - TMS derivatization - quantitation

• References

• 1 Murray RM, Morrison PD, Henquet C, Di Forti M. Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 2007; 8: 885-895
• 2 Baron EP. Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip itʼs been …. Headache 2015; 55: 885-916
• 3 Cerdá M, Wall M, Keyes KM, Galea S, Hasin D. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend 2012; 120: 22-27
• 4 Fairman BJ. Trends in registered medical marijuana participation across 13 US states and District of Columbia. Drug Alcohol Depend 2016; 159: 72-79
• 5 ElSohly MA, Gul W. Constituents of Cannabis sativa . In: Pertwee RG. ed. Hand Book of Cannabis. Oxford: Oxford University Press; 2014: 3-22
• 6 Turner CE, ElSohly MA, Boeren EG. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod 1980; 43: 169-234
• 7 ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. In: Kinghorn AD, Falk H, Gibbons S, Kobayashi J, eds. Progress in the Chemistry of organic natural Products. Cham, Switzerland: Springer 2017; 103: 1-36
• 8 Williamson EM, Evans FJ. Cannabinoids in clinical practice. Drugs 2000; 60: 1303-1314
• 9 Grotenhermen F, Russo E. eds. Cannabis and Cannabinoids: Pharmacology, Toxicology, and therapeutic Potential. New York: Haworth Press; 2003: 123-132
• 10 Garb S. Cannabinoids in the management of severe nausea and vomiting from cancer chemotherapy. Some additional considerations. J Clin Pharmacol 1981; 21: 57S-59S
• 11 Lewis DY, Brett RR. Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, 9-tetrahydrocannabinol (THC) and the anandamide analog, OMDM-2. Eur Neuropsychopharmacol 2010; 20: 622-631
• 12 De Lago E, Gomez-Ruiz M, Moreno-Martet M, Fernandez-Ruiz J. Cannabinoids, multiple sclerosis, and neuroprotection. Exp Rev Clin Pharmacol 2009; 2: 645-660
• 13 Maurer M, Henn V, Dittrich A, Hofmann A. 9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiatr Clin Neurosci 1990; 240: 1-4
• 14 Esposito G, De Filippis D, Maiuri MC, De Stefano D, Carnuccio R, Iuvone T. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement. Neurosci Lett 2006; 399: 91-95
• 15 Pertwee RG. The diverse CB₁ and CB₂ receptor pharmacology of three plant cannabinoids: Δ⁹-tetrahydrocannabinol, cannabidiol, and Δ⁹-tetrahydrocannabivarin. Br J Pharmacol 2008; 15: 199-215
• 16 Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, Orlando P, Battista G, Pagano E, Di Marzo V, Izzo AA. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol 2013; 85: 1306-1316
• 17 Fischedick JT, Glas R, Hazekamp A, Verpoorte R. A qualitative and quantitative HPTLC densitometry method for the analysis of cannabinoids in Cannabis sativa L. Phytochem Anal 2009; 20: 421-426
• 18 Tewari SN, Harpalani SP, Sharma SC. Separation and identification of the constituents of hashish (Cannabis indica linn.) by thin-layer chromatography and its application in forensic analysis. Chromatographia 1974; 7: 205-206
• 19 Upton R, Craker L, ElSohly M, Romm A, Russo E, Sexton M. eds. Cannabis Inflorescence, Cannabis spp. Standards of Identity, Analysis and Quality Control. Scottʼs Valley: American Herbal Pharmacopoeia; 2013
• 20 Oier A, Umut S, Ekin Ö, Daniele S, Yilmaz S, Patricia N, Nestor E, Aresatz U. Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes. J Nat Prod 2016; 79: 324-331
• 21 Omar J, Olivares M, Alzaga M, Etxebarria N. Optimization and characterization of marihuana extracts obtained by supercritical fluid extraction and focused ultrasound extraction and retention time locking GC-MS. J Sep Sci 2013; 36: 1397-1404
• 22 Yotoriyama M, Ishiharajima E, Kato Y, Nagato A, Sekita S, Watanabe K, Yamamoto I. Identification and determination of cannabinoids in both commercially available and cannabis oils stored long term. J Health Sci 2005; 51: 483-487
• 23 De Backer B, Debrus B, Lebrun P, Theunis L, Dubois N, Decock L, Verstraete A, Hubert P, Charlier C. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 4115-4124
• 24 Giese MW, Lewis MA, Giese L, Smith KM. Development and validation of a reliable and robust method for the analysis of cannabinoids and terpenes in cannabis. J AOAC Int 2015; 98: 1503-1522
• 25 Gul W, Gul SW, Radwan MM, Wanas AS, Mehmedic Z, Khan IA, Sharaf MH, ElSohly MA. Determination of 11 cannabinoids in biomass and extracts of different varieties of cannabis using high-performance liquid chromatography. J AOAC Int 2015; 98: 1523-1528
• 26 Fischedick JT, Hazekamp A, Erkelens T, Choi YH, Verpoorte R. Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry 2010; 71: 2058-2073
• 27 Heo S, Yoo GJ, Choi JY, Park HJ, Do JA, Cho S, Baek SY, Park SK. Simultaneous analysis of cannabinoid and synthetic cannabinoids in dietary supplements using UPLC with UV and UPLC–MS-MS. J Anal Toxicol 2016; 40: 350-359
• 28 Aizpurua-Olaizola O, Omar J, Navarro P, Olivares M, Etxebarria N, Usobiaga A. Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry. Anal Bioanal Chem 2014; 406: 7549-7560
• 29 Wang YH, Avula B, ElSohly MA, Radwan MM, Wang M, Wanas AS, Mehemdic Z, Khan IA. UHPLC-UV/MS fingerprint method for quantitative determination of THC, CBD, CBG, and other eight cannabinoids from Cannabis sativa L. varieties. Planta Med 2015; 81: PA25
• 30 Wang M, Wang YH, Avula B, Radwan MM, Wanas AS, Mehmedic Z, ElSohly MA, Khan IA. Quantitative determination of cannabinoids in cannabis and cannabis products using ultra-high-performance supercritical fluid chromatography and diode array/mass spectrometric detection. J Forensic Sci 2017; 62: 602-611
• 31 Toyoʼoka T, Kikura-Hanajiri R. A reliable method for the separation and detection of synthetic cannabinoids by supercritical fluid chromatography with mass spectrometry, and its application to plant products. Chem Pharm Bull 2015; 63: 762-769
• 32 Backstrom B, Cole MD, Carrott MJ, Jones DC, Davidson G, Coleman K. A preliminary study of the analysis of cannabis by supercritical fluid chromatography with atmospheric pressure chemical ionization mass spectroscopic detection. Sci Justice 1997; 37: 91-97
• 33 Later DW, Richter BE, Knowles DE, Andersen MR. Analysis of various classes of drugs by capillary supercritical fluid chromatography. J Chromatogr Sci 1986; 24: 249-253
• 34 Breitenbach S, Rowe WF, McCord B, Lurie IS. Assessment of ultra-high performance supercritical fluid chromatography as a separation technique for the analysis of seized drugs: applicability to synthetic cannabinoids. J Chromatogr A 2016; 1440: 201-211
• 35 Radwan MM, Wanas AS, Chandra S, ElSohly MA. Natural Cannabinoids of Cannabis and Methods of Analysis. In: Chandra S, Lata H, ElSohly M. eds. Cannabis sativa L. – Botany and Biotechnology. Berlin: Springer International Publishing; 2017: 161-182
• 36 Wang M, Wang YH, Avula B, Radwan MM, Wanas AS, van Antwerp J, Parcher JF, ElSohly MA, Khan IA. Decarboxylation study of acidic cannabinoids: a novel approach using ultra-high-performance supercritical fluid chromatography/photodiode array-mass spectrometry. Cannabis Cannabinoid Res 2016; 1: 262-271
• 37 Fetterman PS, Doorenbos NJ, Keith ES, Quimby MW. A simple gas liquid chromatography procedure for determination of cannabinoidic acids in Cannabis sativa L. Experientia 1971; 27: 988-990
• 38 Turner CE, Hadley KW, Henry J, Mole ML. Constituents of Cannabis sativa L. VII: Use of silyl derivatives in routine analysis. J Pharm Sci 1974; 63: 1872-1876
• 39 ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF. Potency trends of Δ⁹-THC and other cannabinoids in confiscated marijuana from 1980–1997. J Forensic Sci 2000; 45: 24-30
• 40 Mehmedic Z, Chandra S, Slade D, Denham H, Foster S, Patel AS, Ross SA, Khan IA, ElSohly MA. Potency trends of Δ⁹-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci 2010; 55: 1209-1217
• 41 ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995–2014): analysis of current data in the United States. Biol Psychiatry 2016; 79: 613-619
• 42 Shoyama Y, Yagi M, Nishioka I, Yamauchi T. Biosynthesis of cannabinoid acids. Phytochemistry 1975; 14: 2189-2192
• 43 ICH. Validation of Analytical Procedures: Text and Methodology. ICH Harmonized Tripartite Guidelines. Available at. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1_Guideline.pdf Accessed August 12, 2015
• 44 Lata H, Chandra S, Techena N, Khan IA, ElSohly MA. In vitro mass propagation of Cannabis sativa L.: a protocol refinement using novel aromatic cytokinin meta-topolin and the assessment of eco-physiological, biochemical and genetic fidelity of micropropagated plants. JARMAP 2016; 3: 1